Explore 3 Stock Ideas & Industry Insights Download Free Report
On 2 September 2026, shares in BioPharma Credit (LSE: BPCR) rose 0.21% to $0.98, broadly unchanged in cents terms on the day, giving the fund aMarket Capitalisationof approximately £807.34m. The trust's US dollar-denominated shares reflect its focus on financing transactions with pharmaceutical companies, many …
On 2 September 2026, shares in Polar Capital Global Healthcare Trust (LSE: PCGH) rose 0.11% to 445.00p, up 0.50p on the day, giving the trust aMarket Capitalisationof approximately £477.50m. The move was modest, consistent with a generally stable session for global healthcare equities. As …
Shares in Hikma Pharmaceuticals (LSE:HIK) rose 4.00p to 1,619.00p, a gain of 0.25% on the day, valuing the company at approximately £3,371.27m. The move places Hikma among today's stronger performers among UK-listed pharmaceutical and healthcare stocks, consistent with an improvement in sentiment toward the …
On 2 September 2026, Oxford Nanopore Technologies (LSE: ONT) shares rose 1.50% to 162.40p, up 2.40p on the day, giving the company aMarket Capitalisationof approximately £1.56bn. The gain came amid a positive session for healthcare and life sciences technology stocks more broadly. As a …
On 2 September 2026, Syncona (LSE: SYNC) shares gained 2.29% to close at 116.00p, up 2.60p on the day, giving the company aMarket Capitalisationof approximately £689.70m. The move came amid a broader lift for healthcare and biotechnology-related stocks in London trading that session. As …
Eden Research plc has returned to investor attention afterLSE:EDEN gained 4.55% on 2 September 2026, putting the small-cap sustainable crop-protection company back on the radar of investors looking for potentially high-growth biotechnology and agricultural innovation opportunities.
ImmuPharma plc has become increasingly interesting to investors afterLSE:IMM gained 5.87% on 2 September 2026.
Aptamer Group plc has become one of the more notable movers among small-cap healthcare stocks, withLSE:APTA rising 10.51%in the latest trading session.
Proteome Sciences has become increasingly interesting to investors because the company'sBusinessis undergoing a significant shift.
Shield Therapeutics has entered September with several important developments converging around its core US business.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…